TINN2 is a European research network (Collaborative Project) supported by the European Commission under the Health Cooperation Work Programme of the 7 th Framework Programme.

News & Events


TINN European Survey on the Use of Antibiotics in NICUs

The survey results are now available and the published article has been published.

Please click here to consult it.


MANY THANKS to all the Neonatal Intensive Care Units that dedicated their time to partipate in the TINN2 survey.


Consortium final meeting on 8th October 2015, in Paris, France

The official event of the TINN2 FP7 European Research Project was organised by Inserm-Transfert on 8th October 2015 in Paris (France).

This meeting gathered together all TINN2 partners for presenting and discussing the latest progresses within TINN2 activities, a project on preclinical studies and paediatric investigation plans for children, under the coordination of the French National Institute of Health and Medical Research (Inserm).

European Congress of Clinical Microbiology and Infectious Diseases, London, United Kingdom 31st to 4th April 2012


TINN2 Project was presented on Poster at the ECCMID congress in London, United Kingdom.

Brochure PDF :

Institut National de la Santé et de la Recherche Médicale (Inserm)

Inserm is a government scientific agency devoted to experimental, translational and clinical research. Clinical research at Inserm is represented by hospital-based clinical research facilities, i.e. research centres (Centres d’Investigation Clinique - CIC). Units steered by both Inserm and University Hospitals.

Evelyne Jacqz-Aigrain MD, PhD, is the national co-ordinator of the French network of paediatric CIC since 2004, with close collaboration with the DRCT Inserm (Department de la Recherche Clinique et Therapeutique). Network of 10 paediatric CIC in France connected with neonatology departments. Inserm U676 laboratory is a research laboratory devoted to physiopathology, functional consequences and neuroprotection of perinatal brain injuries, with experts conducting pre clinical studies in juvenile animals and involved in the validation of preclinical procedures to identify risks for developmental toxicity in humans.

Evelyne Jacqz-Aigrain has a long-standing experience in studies and co-ordination of trials in neonates. (Harmonising the practices, facilitating multicenter studies).


Back to the list of institutions